Current status:
Cancelled Post Market
Current status date:
2013-08-19
DIN:
02354993
Electronic product monograph is not available
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
American Hospital Formulary Service (AHFS):
See footnote 3
52:16.00
,
36:58.00
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01JA51 FLUORESCEIN, COMBINATIONS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
BENOXINATE HYDROCHLORIDE
|
0.4 %
|
FLUORESCEIN SODIUM
|
0.25 %
|